Cambrex Announces Strategic Agreement with Lilly to Support Biotech Collaborator Manufacturing
12.05.2024
Cambrex announces it has signed an agreement with Eli Lilly and Company (Lilly) to deliver accelerated access to clinical development capabilities for their biotech collaborators through Lilly Catalyze360-ExploR&D, Lilly’s early external innovation and collaboration arm.
Read More
